EFFICACY AND SAFETY OF LUSUTROMBOPAG IN PERSISTENT OR CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A PROSPECTIVE, OPEN-LABEL, SINGLE-ARM PHASE II STUDY

Authors
Category Primary study
Conference31st Congress of the European Hematology Association Congress, EHA 2026
Year 2026
This article has no abstract
Epistemonikos ID: 9ed63fe8042db9c6eaf645311c0bdd9135bad30a
First added on: Aug 08, 2026